Significance of gut microbiota in alcoholic and non-alcoholic fatty liver diseases

被引:15
|
作者
Sharma, Satya Priya [1 ]
Suk, Ki Tae [1 ]
Kim, Dong Joon [1 ]
机构
[1] Hallym Univ, Coll Med, Inst Liver & Digest Dis, Chunchon 24252, South Korea
基金
新加坡国家研究基金会;
关键词
Fatty liver disease; Alcoholic fatty liver disease; Non-alcoholic fatty liver disease; Gut microbiome; Dysbiosis; INTESTINAL MICROBIOTA; FECAL MICROBIOTA; BILE-ACIDS; DYSBIOSIS; HOST; BACTERIAL; SUPPLEMENTATION; CIRRHOSIS; FIBROSIS; ETHANOL;
D O I
10.3748/wjg.v27.i37.6161
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Liver-gut communication is vital in fatty liver diseases, and gut microbes are the key regulators in maintaining liver homeostasis. Chronic alcohol abuse and persistent overnutrition create dysbiosis in gut ecology, which can contribute to fatty liver disease. In this review, we discuss the gut microbial compositional changes that occur in alcoholic and nonalcoholic fatty liver diseases and how this gut microbial dysbiosis and its metabolic products are involved in fatty liver disease pathophysiology. We also summarize the new approaches related to gut microbes that might help in the diagnosis and treatment of fatty liver disease.
引用
收藏
页码:6161 / 6179
页数:19
相关论文
共 50 条
  • [41] Sphingolipid metabolism in non-alcoholic fatty liver diseases
    Regnier, Marion
    Polizzi, Arnaud
    Guillou, Herve
    Loiseau, Nicolas
    [J]. BIOCHIMIE, 2019, 159 : 9 - 22
  • [42] DYSFUNCTION OF AUTOPHAGY IS INVOLVED IN THE PROGRESSION OF ALCOHOLIC AND NON-ALCOHOLIC FATTY LIVER DISEASES
    Yamashina, S.
    Ikejima, K.
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2018, 42 : 110A - 110A
  • [43] NON-ALCOHOLIC FATTY LIVER
    Carretto, Federico
    [J]. REVISTA MEDICA DE ROSARIO, 2021, 87 (02): : 87 - 88
  • [44] Assessment of Intestinal Microbiota in Non-Alcoholic Fatty Liver Disease
    Mouzaki, Marialena
    Arendt, Bianca M.
    Fischer, Sandra E.
    Comelli, Elena M.
    Allard, Johane P.
    [J]. HEPATOLOGY, 2012, 56 : 243A - 243A
  • [45] Gut microbia dysbiosis in non-alcoholic fatty liver disease
    Guss, Debra A.
    Mohanty, Smruti R.
    [J]. TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S152 - S155
  • [46] CLINICAL CHARACTERISTICS AND GUT MICROBIOTA FEATURES IN PATIENTS OF COMORBID INFLAMMATORY BOWEL DISEASES AND NON-ALCOHOLIC FATTY LIVER DISEASE
    Zhou, Chen
    Zhang, Lu
    Li, Jun
    Li, Junxia
    Duan, Li-Ping
    [J]. GASTROENTEROLOGY, 2022, 162 (07) : S515 - S516
  • [47] Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
    Eslami, Layli
    Merat, Shahin
    Malekzadeh, Reza
    Nasseri-Moghaddam, Siavosh
    Aramin, Hermineh
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (12):
  • [48] Dysbiosis of gut microbiota after cholecystectomy is associated with non-alcoholic fatty liver disease in mice
    Wang, Qihan
    Lu, Qifan
    Shao, Wentao
    Jiang, Zhaoyan
    Hu, Hai
    [J]. FEBS OPEN BIO, 2021, 11 (08): : 2329 - 2339
  • [49] Polyphenols improve non-alcoholic fatty liver disease via gut microbiota: A comprehensive review
    Mohammadhasani, Kimia
    Fard, Mohammad Vahedi
    Shahri, Ali Mottaghi Moghaddam
    Khorasanchi, Zahra
    [J]. FOOD SCIENCE & NUTRITION, 2024, 12 (08): : 5341 - 5356
  • [50] Effect of Kombucha on gut-microbiota in mouse having non-alcoholic fatty liver disease
    Youngmi Jung
    Inyoung Kim
    Mohamed Mannaa
    Jinnyun Kim
    Sihyung Wang
    Inmyoung Park
    Jieun Kim
    Young-Su Seo
    [J]. Food Science and Biotechnology, 2019, 28 : 261 - 267